New decision aid for treatment of herniated disc beneficial

New decision aid for treatment of herniated disc beneficial
A new patient decision instrument meets the criteria of acceptability, reliability, and validity, and improves the quality of patient decision-making for treatment for a herniated disc, according to a study published in the Aug. 15 issue of Spine.

(HealthDay)—A new patient decision instrument meets the criteria of acceptability, reliability, and validity, and improves the quality of patient decision-making for treatment of a herniated disc, according to a study published in the Aug. 15 issue of Spine.

Karen R. Sepucha, Ph.D., from Massachusetts General Hospital in Boston, and colleagues developed and evaluated a -decision quality instrument (HD-DQI). The instrument generates two scores—a total knowledge score and a concordance score—each scaled 0 to 100 percent, with higher scores indicating better quality.

The researchers found that the HD-DQI survey was feasible for implementation and acceptable to patients. There were good response rates and limited missing data. The knowledge score was able to differentiate significantly between patients who had seen a decision aid or not (55 versus 38 percent) and between providers and patients (73 versus 46 percent). There was also good retest reliability (intraclass correlation coefficient, 0.85) with the knowledge score. The majority of patients (78 percent) were given treatments that matched their goals, and these patients were significantly less likely to regret their decision than those whose treatments did not match their goals (13 versus 39 percent).

"The HD-DQI met several criteria for high-quality patient-reported survey instruments," the authors write. "More work is needed to examine acceptability for use as part of routine patient care."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Who will benefit from stroke drug? New score can help decide

Feb 06, 2012

A new scoring method can help doctors quickly decide which stroke patients will respond well to the clot-busting drug alteplase, according to a study published in the February 7, 2012, print issue of Neurology, the medica ...

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.